Evaluating the Effectiveness of the Health App Recommendation Tool
NCT07216716
Summary
This study aims to assess the effectiveness of the Health App Recommendation Tool (HART), an evidence-based tool that evaluates app features and matches them to the needs, abilities, and preferences of individuals with Alzheimer's disease and related dementias (ADRD) or their caregivers. This novel tool is not an app in and of itself, but rather an assessment tool used to determine how well suited a given app is for a member of the ADRD or caregiver population. Specifically, the objective of this research is to assess the acceptability of the current HART design among target end-users in their individual contexts. The overarching goal of this project is to connect those in the ADRD community with available, usable, and effective digital tools to promote the highest possible level of health and wellness in community settings. To achieve this goal, the study will recruit 15 family caregivers living with their loved ones with ADRD, who will trial HART and provide feedback. Participation will include two data collection sessions (pre-intervention and post-intervention) within a four-week trial period. Participants will be asked to complete the HART, explore the recommended apps, and provide feedback on HART's usability through several brief surveys.
Eligibility
Inclusion Criteria: * Aged between 18 and 65 * Serving as an active caregiver for a loved one with Alzheimer's disease or a related dementia * Have access to smart devices such as smartphones, tablets, or smartwatches Exclusion Criteria: * Individuals with Alzheimer's disease or a related dementia, or with severe cognitive decline, will be excluded * Participants who do not provide caregiving on a routine basis (e.g., part-time or secondary caregivers) will be excluded * Participants who do not own or have access to any smart device will be excluded
Conditions2
Locations1 site
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT07216716